Analyst Research

Report Title Price
Thomson Reuters Stock Report - OSSTEM IMPLANT CO., LTD. (048260-KQ)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Osstem Implant Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Wright Investors Service Comprehensive Report for Osstem Implant Co., Ltd.
Provider: Wright Reports
$472.00
Buy
Osstem Implant Co., Ltd. (048260) - Financial Analysis Review
Provider: GlobalData
$125.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

OSSTEM IMPLANT CO Ltd Issues FY 2012 Revenue Outlook Above Analysts' Estimates


Thursday, 16 Aug 2012 04:28am EDT 

OSSTEM IMPLANT CO Ltd announced that it expects the revenue and Operating Profit for the fiscal year 2012 to record KRW 210 billion and KRW 29.4 billion. According to I/B/E/S, analysts on average are expecting the Company to report revenue of KRW 148.88 for fiscal year 2012. 

Latest Key Developments in Medical

Company Quote

Osstem Implant Co Ltd
(048260.KQ)
31150.0
100.0 +0.32%
24 May 2013